Home
/
Treatment
/
Propanoic acid, 2,2-dimethyl-,1,1′-[[[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]phosphinylidene]bis(oxymethylene)] ester

Propanoic acid, 2,2-dimethyl-,1,1′-[[[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]phosphinylidene]bis(oxymethylene)] ester

	Propanoic acid, 2,2-dimethyl-,1,1′-[[[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]phosphinylidene]bis(oxymethylene)] ester
Trade Name
Orphan Indication	Alport syndrome
USA Market Approval	USA
USA Designation Date	2016-12-05 00:00:00
Sponsor	Viking Therapeutics, Inc.;12340 El Camino Real, Suite 250;San Diego, California, 92130